Tracked deals
3
3 tracked deals across 2022-2024.
Chapel Hill, North Carolina, United States
Formerly known as ACRS, ACRS (American Clinical Research Services), ACRS Clinical Research
Elixia is a clinical site organization (SMO) providing patient recruitment and clinical trials management and analysis across multiple therapeutic areas, including Phase I–IV trials.
Tracked deals
3
3 tracked deals across 2022-2024.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
3 addon
Last 3 years
Supporting Data
American Clinical Research Services (ACRS), a clinical research platform formed by Latticework Capital Management, has acquired Elixia, a multi-specialty clinical research site network operating in Florida, Massachusetts, Michigan and Missouri. The acquisition expands ACRS's footprint and capabilities in complex therapeutic areas—notably nephrology, neuroscience and infectious diseases—and adds Elixia's 40-bed Phase I unit in Tampa to ACRS's national site network.
ACRS, a site management organization platform backed by Latticework Capital Management, has acquired Clinical Site Services (CSSi) and Patient Advertising Guru (PAG). The add-on deals expand ACRS's patient recruitment, media/advertising and local enrollment capabilities to support clinical trial enrollment across multiple therapeutic areas and geographies.
Dallas-based private equity firm Latticework Capital Management formed American Clinical Research Services Holdings (ACRS) and, through the new platform, acquired Montclair, California–based Catalina Research Institute, LLC (CRI). The deal establishes an SMO platform focused on complex clinical trials and patient diversity to scale site operations, improve trial efficiencies and expand CRI's reach; financial terms were not disclosed.
Turn tracked acquisition activity into an outreach-ready buyer list.